Publisher： John Wiley & Sons Inc
E-ISSN： 1521-3773|54|35|10244-10248
ISSN： 1433-7851
Source： ANGEWANDTE CHEMIE INTERNATIONAL EDITION, Vol.54, Iss.35, 2015-08, pp. : 10244-10248
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
AbstractSustained identification of innovative chemical entities is key for the success of chemical biology and drug discovery. We report the fragment‐based, computer‐assisted de novo design of a small molecule inhibiting Helicobacter pylori HtrA protease. Molecular binding of the designed compound to HtrA was confirmed through biophysical methods, supporting its functional activity in vitro. Hit expansion led to the identification of the currently best‐in‐class HtrA inhibitor. The results obtained reinforce the validity of ligand‐based de novo design and binding‐kinetics‐guided optimization for the efficient discovery of pioneering lead structures and prototyping drug‐like chemical probes with tailored bioactivity.
Related content
Fragment‐Based De Novo Design Reveals a Small‐Molecule Inhibitor of Helicobacter Pylori HtrA
ANGEWANDTE CHEMIE, Vol. 127, Iss. 35, 2015-08 ,pp. :
Access to resources
Recommend
De Novo Fragment Design for Drug Discovery and Chemical Biology
ANGEWANDTE CHEMIE INTERNATIONAL EDITION, Vol. 54, Iss. 50, 2015-12 ,pp. :